Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study

Won, 2013, Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer, BJU Int, 112, E250, 10.1111/bju.12169 Sooriakumaran, 2016, A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation, Eur Urol, 69, 788, 10.1016/j.eururo.2015.05.023 Gratzke, 2014, Role of radical prostatectomy in metastatic prostate cancer: data from the Munich cancer registry, Eur Urol, 66, 602, 10.1016/j.eururo.2014.04.009 Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012 Fossati, 2015, Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study, Eur Urol, 67, 3, 10.1016/j.eururo.2014.08.056 Gandaglia G, Fossati N, Stabile A, Bandini M, Rigatti P, Montorsi F, et al. Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.08.040 Heidenreich, 2015, Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study, J Urol, 193, 832, 10.1016/j.juro.2014.09.089 Berg, 2015, The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy, Prostate, 75, 1499, 10.1002/pros.23026 Zilli, 2016, Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: a systematic review of the literature, Cancer Treat Rev, 46, 35, 10.1016/j.ctrv.2016.03.016 Bournakis, 2011, Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival, Anticancer Res, 31, 1475